Rheumatology NewsCV risk biomarkers tentatively identified in psoriatic diseaseMarch 11, 2022Psoriatic Arthritis
Rheumatology NewsDrug survival study looks at what lasts longest in RA, axSpA, PsA, and psoriasisMarch 11, 2022SpondyloarthropathiesRheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitis
Rheumatology NewsMethotrexate plus leflunomide proves effective for PsAMarch 8, 2022Psoriatic Arthritis
Rheumatology NewsUpdated perioperative guidance says when to hold antirheumaticsMarch 4, 2022Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesAnkylosing spondylitisOrthopedics
Rheumatology NewsOne-third of psoriatic arthritis patients could have metabolic syndrome, data analysis findsMarch 4, 2022Psoriatic ArthritisMixed Topics
PsA: TNF-blockade does not downregulate IL-17 cytokine and receptor protein levelFebruary 23, 2022Psoriatic Arthritis
Sex-specific adjustments in management strategy may be beneficial in early PsAFebruary 23, 2022Psoriatic Arthritis
PsA: Patients have high anxiety levels that decline after initiation of biologicsFebruary 23, 2022Psoriatic Arthritis
MIC of PASDAS could serve as an additional tool to understand patients’ perspectives of PsAFebruary 23, 2022Psoriatic Arthritis
Doppler signals and bone erosions at enthesis indicate more severe PsAFebruary 23, 2022Psoriatic Arthritis
PsA: Time to clinically meaningful response shorter with tofacitinib vs. placeboFebruary 23, 2022Psoriatic Arthritis
